Skip to main content
. 2018 Apr 25;2018(4):CD011689. doi: 10.1002/14651858.CD011689.pub2
Methods 2‐arm active‐controlled randomised trial.
Participants Between dates unspecified, 148 parturients were randomised in a hospital setting in the UK. The population comprised women of unspecified parity, a singleton pregnancy, at high risk for PPH, who delivered by vaginal delivery. Exclusion criteria were not specified.
Interventions 500 mcg of ergometrine administered by an intravenous bolus (n = 78) versus 5 IU of oxytocin administered by an intravenous bolus (n = 70).
Outcomes The study recorded the following outcomes: PPH at 500, blood loss (mL), nausea.
Notes Contact with study authors for additional information: no. Additional data from authors: no.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Randomisation sequence generation was not reported.
Allocation concealment (selection bias) Unclear risk Allocation concealment was not reported.
Blinding of participants and personnel (performance bias) All outcomes Unclear risk Blinding (of study participants and caregivers) was not reported.
Blinding of outcome assessment (detection bias) All outcomes Unclear risk Assessor blinding was not reported.
Objective assessment of blood loss Low risk Investigators evaluated blood loss by collection with the placenta bowl and soiled linen and swabs. "The principles of the haemoglobin extraction‐dilution technique employed have been discussed by Roe, Gardiner and Dudley (1962) and Thornton and colleagues (1963)."
Incomplete outcome data (attrition bias) All outcomes High risk There were 148 study participants but blood loss data were available in only 80 cases.
Selective reporting (reporting bias) Unclear risk The protocol of the study was unavailable for verification.
Intention to treat analysis Low risk All those who were enrolled and randomly allocated to treatment were included in the analysis, in the groups to which they were randomised.
Funding source Unclear risk Source(s) of funding for the study were not reported.